GHK-Cu: What the Research Shows

For laboratory and research use only. This article summarises published scientific research on GHK-Cu. Neurovia’s GHK-Cu is not intended for human consumption. See our disclaimer.

GHK-Cu: What the Research Shows

GHK-Cu is one of the most studied copper-peptide complexes in biological research. Originally isolated from human plasma in the early 1970s, it has since been investigated across a broad range of research contexts — from wound healing and skin biology to gene expression and antioxidant activity.

This article provides an evidence-based overview of GHK-Cu: its molecular identity, the published research landscape, its proposed mechanisms, and its supply format for laboratory use.

What Is GHK-Cu?

GHK-Cu is a naturally occurring copper peptide complex consisting of the tripeptide Glycyl-L-histidyl-L-lysine (GHK) bound to a copper (II) ion (Cu²⁺).

Molecular profile:

  • Peptide: Gly-His-Lys (3 amino acids)
  • Full complex: GHK-Cu²⁺
  • Molecular weight: ~340 Da (peptide alone); ~403 Da (copper complex)
  • CAS Number: 49557-75-7 (GHK-Cu)

GHK was first isolated from human plasma albumin by Loren Pickart in 1973, in research published in Nature. The discovery established that GHK was present in human plasma and that its concentration declined with age — a finding that has driven much of the subsequent research interest in this molecule.

The copper(II) ion is integral to GHK’s biological activity in research contexts. Copper is an essential trace element involved in numerous enzymatic processes, and the GHK-Cu complex has been shown to have significantly different biological activity from the GHK tripeptide alone in published research.

The Published Research Landscape

Wound Healing Research

The earliest and most extensive GHK-Cu research concerns wound healing. Published studies in animal models have examined GHK-Cu’s studied effects on wound contraction, collagen synthesis, and angiogenesis in cutaneous wound models.

Loren Pickart’s group and subsequent independent researchers have published extensively on GHK-Cu in wound healing contexts, with work appearing in journals including Life Sciences, Proceedings of the Society for Experimental Biology and Medicine, and International Journal of Cosmetic Science.

Published preclinical studies have investigated GHK-Cu’s relationship with:

  • Collagen synthesis — studies examining its interaction with fibroblast activity and collagen type I and III production in cell culture and animal models
  • Angiogenesis — research on its studied relationship with blood vessel formation in wound bed models
  • Wound contraction — animal model studies examining the rate and quality of wound closure

Skin Biology Research

A significant body of research has investigated GHK-Cu in skin biology contexts. Published studies have examined its interactions with keratinocyte and fibroblast activity, extracellular matrix remodelling, and skin barrier function in cell culture and preclinical models.

This research has positioned GHK-Cu as one of the most investigated compounds in cosmetic and dermatological research peptide science, with published work from multiple independent research groups worldwide.

Gene Expression Research

One of the more recent and extensively published areas of GHK-Cu research concerns its effects on gene expression. Research by Pickart and Margolina, published in Biochemistry Research International and other journals, has reported that GHK-Cu modulates the expression of a large number of genes in human cell cultures — including genes associated with:

  • Collagen and ECM remodelling — upregulation of collagen synthesis genes and matrix metalloproteinase regulation
  • Antioxidant defence — studied relationship with superoxide dismutase and other antioxidant enzyme genes
  • Anti-inflammatory pathways — examined interactions with NFκB signalling in cell culture studies
  • Neurological gene expression — a smaller body of research has examined GHK-Cu’s interaction with nerve growth factor (NGF) and BDNF-related genes in neuronal cell culture models

It is important to note that gene expression studies in cell culture represent early-stage research and do not constitute evidence of clinical effects in humans.

Hair Follicle Research

Published preclinical research has examined GHK-Cu in hair follicle biology contexts, including studies on follicle size and hair cycle regulation in animal models. This research is distinct from cosmetic marketing claims — it represents published laboratory investigation into GHK-Cu’s interactions with follicular biology at the cellular level.

Proposed Mechanism of Action

The mechanisms through which GHK-Cu exerts its studied effects are not fully characterised, but published research has proposed several pathways:

Copper chaperone activity — GHK-Cu may act as a copper delivery system, facilitating the activity of copper-dependent enzymes such as lysyl oxidase (involved in collagen cross-linking) and superoxide dismutase (antioxidant defence).

Fibroblast activation — Multiple published studies have examined GHK-Cu’s interaction with fibroblast proliferation and collagen synthesis in cell culture, suggesting direct cellular effects independent of its copper-carrying function.

Proteasome activation — Research has investigated GHK-Cu’s interaction with the ubiquitin-proteasome system, proposing a mechanism by which it may influence protein degradation and cellular repair processes.

TGF-β interaction — Some published research has proposed interactions with TGF-β (transforming growth factor beta) signalling, which is implicated in ECM remodelling and wound healing contexts.

GHK-Cu vs Other Copper Peptides

GHK-Cu is the most researched copper peptide by a significant margin, but it is not the only copper peptide studied in research contexts. Copper peptides differ in:

  • Peptide sequence — different amino acid chains with different receptor affinities and biological activity profiles
  • Copper affinity — the binding strength of the copper ion varies between different copper peptide complexes
  • Stability — some copper peptides are more stable in solution than others

GHK-Cu’s position in the research literature is established by the depth and breadth of its published research base, originating from its discovery in human plasma and extending across multiple biological contexts over 50+ years.

Supply Format for Research

GHK-Cu is supplied for laboratory research in several formats to support different experimental designs:

Neurovia supplies GHK-Cu in the following research formats:

All supplied at 99% purity, third-party tested, with Certificate of Analysis available.

Further reading: peer-reviewed research on the compound (PubMed).

Frequently Asked Questions

What is this compound peptide?

it is a naturally occurring copper peptide complex consisting of the tripeptide Glycyl-L-histidyl-L-lysine (GHK) bound to a copper(II) ion. First isolated from human plasma in 1973 by Loren Pickart, it has been studied extensively in wound healing, skin biology, and gene expression research contexts.

How does the peptide work in research?

Published research proposes several mechanisms: copper chaperone activity supporting copper-dependent enzymes, direct fibroblast activation in cell culture, proteasome modulation, and interactions with TGF-β signalling. The exact primary mechanism remains an area of active investigation.

What research has been done on the compound?

this compound has been studied in wound healing, skin biology, gene expression, hair follicle biology, and antioxidant contexts. Published research spans over 50 years across multiple independent research groups, with Loren Pickart’s group conducting foundational work and numerous subsequent independent studies.

What is the difference between it and other copper peptides?

the peptide differs from other copper peptides in its specific amino acid sequence (Gly-His-Lys), its natural occurrence in human plasma, and its extensive published research base. Other copper peptides have different sequences and potentially different biological activity profiles in research contexts.

What is the compound skin research?

this compound skin research encompasses published preclinical studies on its interactions with fibroblasts, collagen synthesis, keratinocytes, ECM remodelling, and wound healing in cell culture and animal models. This research is distinct from cosmetic product claims and represents published laboratory science.

Does it occur naturally in humans?

Yes. GHK was first isolated from human plasma albumin by Loren Pickart in 1973. Research has subsequently shown that plasma GHK concentrations decline with age — a finding that has been a significant driver of research interest in this molecule.

How is the peptide supplied for research?

the compound is available for research as a lyophilised powder or in topical serum formats, depending on the research application. Neurovia supplies this compound at 99% purity with third-party Certificate of Analysis available.

This article summarises published peer-reviewed research on it and is provided for informational purposes only. Neurovia’s the peptide is supplied for laboratory research use only and is not intended for human consumption. Full disclaimer →

Related Reading

Labs comparing peptide classes may also be interested in the growth hormone secretagogue research on Sermorelin, Ipamorelin & CJC-1295.